drugset / Trial / NCT01128582

Effect of Rozerem on the Perception of GERD Symptoms in Patients With Chronic Insomnia.

NCT01128582

Phase 3 Unknown 40 enrolled Southern Arizona VA Health Care System
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To determine if administration of Rozerem in comparison to a placebo reduces or eliminates gastroesophageal reflux disease(GERD) symptoms in individuals with both GERD and chronic insomnia.

Timeline

Start
2009-03
Primary completion
2011-12
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ramelteon Unknown 8 mg